kaiser semaglutide criteria Population‐level impact of 2.4 mg in patients with obesity or overweight and cardiovascular disease: A modelling study based on the SELECT trial - Nanna - 2025 - Diabetes, Obesity and Metabolism Prescription Drug Plan Archives -

Anyone starting semaglutidewhether compounded through a licensed 503A pharmacy or brandedshould verify expiration dates upon delivery, confirm refrigeration equipment is functional, and discuss storage questions with their provider or pharmacy

While tirzepatide can produce more pronounced weight loss, higher doses may also increase the likelihood of gastrointestinal side effects

This becomes particularly important when working with compounded semaglutide formulations where concentrations vary between pharmacies

Furthermore, the deletion of Bmal1 in the brain induced apoE expression (inhibiting, e.g., astrocytic clearance of A [73]), potentially elucidating how circadian disruption may increase A burden in the brain